Imaging in Heart Transplant Patients

Area of Science:

• Cardiology
• Transplantation Immunology
• Medical Imaging

Background:

• Heart transplantation is a life-saving treatment for end-stage heart failure, with survival exceeding 10 years due to improved immunosuppression.
• Graft rejection and cardiac allograft vasculopathy remain significant threats to long-term heart transplant success.
• Unlike other transplants, heart transplantation lacks validated biomarkers for rejection detection, necessitating invasive monitoring.

Purpose of the Study:

• To review current invasive and noninvasive imaging modalities for monitoring heart transplant recipients.
• To examine emerging imaging techniques for assessing cardiac allograft rejection and vasculopathy.
• To highlight the need for improved, less invasive methods for early detection of heart transplant complications.

Main Methods:

• Review of existing literature on cardiac allograft monitoring techniques.
• Analysis of standard-of-care invasive methods: endomyocardial biopsy and coronary angiography.
• Evaluation of novel and emerging noninvasive and minimally invasive imaging modalities.

Main Results:

• Endomyocardial biopsy and coronary angiography are standard but invasive and have limitations.
• Advanced echocardiography, CT, MRI, and PET show promise for noninvasive rejection exclusion.
• Intravascular ultrasound and OCT offer enhanced resolution for coronary artery assessment.

Conclusions:

• Current monitoring for heart transplant rejection relies on invasive procedures with inherent risks.
• Emerging imaging technologies offer potential for less invasive and more accurate graft surveillance.
• Further research and validation of newer techniques are essential to improve heart transplant outcomes.